SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Balance Sheet
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹-348 Cr | ₹4.33 Cr | ₹276 Cr |
What is the latest Net Current Assets ratio of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹-348 Cr |
| Mar2024 | ₹4.33 Cr |
| Mar2023 | ₹276 Cr |
How is Net Current Assets of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹-348 Cr | Negative | |
| Mar2024 | ₹4.33 Cr | -98.43 | |
| Mar2023 | ₹276 Cr | - | |
Compare Net Current Assets of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹7,716.6 Cr | -0.3% | 31.8% | 45.9% | Stock Analytics | |
| SAGILITY | ₹18,748.7 Cr | 0.3% | -3.4% | -0.8% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹17,900.7 Cr | -2.2% | -5.7% | -33.2% | Stock Analytics | |
| PRIME FOCUS | ₹17,417.1 Cr | -4.2% | -11.2% | 88.1% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹15,514.5 Cr | -2.2% | -4.4% | -7.5% | Stock Analytics | |
| INDEGENE | ₹13,036.4 Cr | 4.9% | 6.4% | -10.3% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -0.3% |
31.8% |
45.9% |
| SENSEX | 1.1% |
2.4% |
-5% |
You may also like the below Video Courses